Alerts will be sent to your verified email
Verify Email
JOHNPHARMA
|
Johnson Pharmacare
|
Jaihind Synthetics
|
Cerebra Integ. Tech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-0.52 % | 0.1 % | -1.34 % |
|
5yr average Equity Multiplier
|
1.03 | 1.08 | 1.52 |
|
5yr Average Asset Turnover Ratio
|
0.02 | 0.0 | 0.3 |
|
5yr Avg Net Profit Margin
|
-9.6 % | 0.0 | -13.9 % |
|
Price to Book
|
0.93 | 3.53 | 0.29 |
|
P/E
|
0.0 | 426.99 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 0.0 | 765.04 Days |
|
Inventory Days
|
0.0 | 0.0 | 113.07 Days |
|
Days Receivable
|
0.0 | 0.0 | 916.46 Days |
|
Days Payable
|
45.33 Days | 378.07 Days | 375.27 Days |
|
5yr Average Interest Coverage Ratio
|
-285.72 | 276.89 | 1.54 |
|
5yr Avg ROCE
|
-0.5 % | 0.12 % | 3.66 % |
|
5yr Avg Operating Profit Margin
|
-9.65 % | 0.0 | -2.53 % |
|
5 yr average Debt to Equity
|
0.02 | 0.03 | 0.11 |
|
5yr CAGR Net Profit
|
17.32 % | 0.0 | n/a |
|
5yr Average Return on Assets
|
-0.5 % | 0.09 % | -0.8 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 9.03 % | 0.84 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.13 % | -6.26 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Johnson Pharmacare
|
Jaihind Synthetics
|
Cerebra Integ. Tech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|